Immunology
-
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
This article has 18 authors:Reviewed by ScreenIT
-
T cells discriminate between groups C1 and C2 HLA-C
This article has 6 authors:This article has been curated by 1 group:Reviewed by eLife
-
Mapping SARS-CoV-2 antigenic relationships and serological responses
This article has 32 authors:Reviewed by ScreenIT
-
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
This article has 44 authors:Reviewed by ScreenIT
-
Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
This article has 22 authors:Reviewed by ScreenIT
-
Germinal center-derived broadly neutralizing antibodies adapt to SARS-CoV-2 antigenic drift
This article has 16 authors:Reviewed by ScreenIT
-
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19
This article has 19 authors:Reviewed by ScreenIT
-
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
This article has 24 authors:Reviewed by ScreenIT
-
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
This article has 10 authors:Reviewed by ScreenIT
-
Cytotoxic T Lymphocytes Targeting a Conserved SARS-CoV-2 Spike Epitope are Efficient Serial Killers
This article has 5 authors:Reviewed by ScreenIT